Evidence map›Paper›PMID 34831361›Full record

ReviewCells2021

Failure Analysis of TEVG's I: Overcoming the Initial Stages of Blood Material Interaction and Stabilization of the Immune Response.

Maria A Rodriguez-Soto, Natalia Suarez Vargas, Alejandra Riveros, Carolina Muñoz Camargo, Juan C Cruz, Nestor Sandoval, Juan C Briceño

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maria A Rodriguez-SotoDepartment of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-9979-2815
Natalia Suarez VargasDepartment of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.
Alejandra RiverosDepartment of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-4421-4815
Carolina Muñoz CamargoDepartment of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0001-6238-9021
Juan C CruzDepartment of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-7790-7546
Nestor SandovalDepartment of Congenital Heart Disease and Cardiovascular Surgery, Fundación Cardio Infantil Instituto de Cardiología, Bogotá 111711, Colombia.
Juan C BriceñoDepartment of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.
Universidad de Los Andes · COInstitute of Cardiology · CO

Funding

Ministerio de Ciencia, Tecnología e Innovación (Minciencias) 277877758172, 819-2017
6 · The paper itself

Abstract

Vascular grafts (VG) are medical devices intended to replace the function of a diseased vessel. Current approaches use non-biodegradable materials that struggle to maintain patency under complex hemodynamic conditions. Even with the current advances in tissue engineering and regenerative medicine with the tissue engineered vascular grafts (TEVGs), the cellular response is not yet close to mimicking the biological function of native vessels, and the understanding of the interactions between cells from the blood and the vascular wall with the material in operative conditions is much needed. These interactions change over time after the implantation of the graft. Here we aim to analyze the current knowledge in bio-molecular interactions between blood components, cells and materials that lead either to an early failure or to the stabilization of the vascular graft before the wall regeneration begins.

Indexed as

Blood Vessel ProsthesisImmunityAnimalsBiocompatible MaterialsBloodBlood CoagulationHumansTreatment FailureBiocompatible Materialsfailureimmune responseregenerationtissue-engineered vascular grafts

Identifiers

PMID34831361
PMCPMC8625197
OpenAlexW3211920172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.